ClinicalTrials.Veeva

Menu
A

Apex Research Foundation | Jackson, TN

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

MK-1242
Vericiguat
Ziltivekimab
Olpasiran
Maridebart Cafraglutide
Tirzepatide
MK-1242-035
LY3298176

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 5 total trials
Locations recently updated

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation (HERMES)

This study will be done to see if ziltivekimab can be used to treat people living with heart failure and inflammation. Participants will either get z...

Enrolling
Heart Failure
Drug: Placebo
Drug: Ziltivekimab
Locations recently updated

This study will examine if maridebart cafraglutide as an adjunct to standard of care will lead to a reduction in heart failure (HF) events such as HF...

Enrolling
Heart Failure With Preserved Ejection Fraction
Obesity
Drug: Placebo
Drug: Maridebart cafraglutide

The primary objective is to evaluate the effect of olpasiran, compared to placebo, on the risk for coronary heart disease death (CHD death), myocardi...

Enrolling
Cardiovascular Disease
Drug: Olpasiran
Drug: Placebo

Trial sponsors

Amgen logo
Lilly logo
Merck Sharp & Dohme (MSD) logo
Novo Nordisk logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems